reports
Agilent Names Simon May to Lead Diagnostics and Genomics Group
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies, Inc. (NYSE: A) today announced Simon May has been named president of the company’s Diagnostics and Genomics Group (DGG). May, previously executive vice president and president of the Life Science Group at Bio-Rad Laboratories, will join Agilent on May 6. “We are excited to welcome Simon May to the Agilent team,” said Padraig McDonnell, COO and CEO-elect. “Simon’s deep technical knowledge, his broad range of experience, and his career-long focus on strategy, continuous improvement and operational excellence are critical additions to...
Agilent Receives Scientists' Choice Awards for Sustainability
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) announces that it is the recipient of two 2023 Sustainability Scientists’ Choice awards — Sustainable Supplier of the Year and Sustainable Product of the Year. These awards recognize Agilent as a leader in the area of sustainability. The award for Sustainable Supplier of the Year, recognizes Agilent’s demonstrated commitment to environmental responsibility and sustainability. The award acknowledges efforts in minimizing environmental impact through thoughtfully designed products, promoting eco-friendly practices, and actively contributing to ...
Agilent Receives European IVDR Class C Certification for GenetiSure Dx...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced that its has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards established by IVDR. It ensures the continued availability of this trusted qualitative assay to clinical geneticists and other healthcare professionals throughout the EU. In vitro diagnostic devices, which include pregnancy tests, COVID-19 tests, urine test strips, and more, are estimated to play a part in 70% of all diagnostic decisions.1 The EU has introduced the IVDR regulatory framework to e...
Agilent Brings Great Science to Life at Analytica 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is scheduled to take place from April 9 to 12 in Munich, Germany. Visit Agilent at Hall A2, Booth 201, to learn about recently introduced products and solutions enabling key workflows that are revolutionizing laboratories across industries including pharma and biopharma, food and environment...
Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A), a global leader in life sciences and diagnostics, announced today its participation in the . At the meeting, which will take place from April 5 to 10, 2024, in San Diego, CA, Agilent will highlight new cell analysis, genomics, digital pathology, and companion diagnostics solutions. Featured products and solutions that play a crucial role in advancing cancer research and diagnostics, will include: Agilent NovoCyte Opteon Spectral Flow Cytometer - The Agilent NovoCyte Opteon Spectral Flow Cytometer, is an advanced solution in spectral flow ...
Agilent and UC San Diego Launch Center of Excellence in Cellular Intel...
SANTA CLARA, Calif. & SAN DIEGO--(BUSINESS WIRE)-- . (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, and the (UC San Diego), one of the top-ranked public research universities in the world, today announced an innovative scientific collaboration to establish the . The Agilent CoE, located at UC San Diego’s School of Medicine, will foster collaboration and innovation among researchers from Agilent and UC San Diego, and other institutions and industry partners. The CoE will serve as a hub for academic and pharma/biopharma researchers in the region, enabl...
Agilent Launches New Advanced Dilution System to Increase Lab Efficien...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the launch of the , the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall efficiency within the laboratory. The Agilent ADS 2 is an intelligent autodilutor designed to enhance laboratory workflows. Designed to integrate seamlessly with Agilent autosamplers, ICP-OES and ICP-MS instruments and software, it offers a fully integrated, single-supplier automated solution. As one of the most trusted brands in the analytical instrument...
Agilent Technologies Inc: 1 director
A director at Agilent Technologies Inc sold 2,827 shares at 147.540USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Agilent Presents 2024 Darlene Solomon Award to University of Cambridge...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) announced today that Joycelyn Tan, a Ph.D. student at the at the , UK, has been awarded the . The award recognizes and supports promising female scientists working in mass spectrometry. Ms. Tan is a member of the , which is dedicated to understanding the mechanisms responsible for obesity and related metabolic diseases. Her research focuses on how culture conditions, such as oxygen tension and medium nutrient composition, can alter the metabolism and function of various metabolic cell types, with the goal of identifying culture conditions th...
Agilent Presents Solutions Innovation Research Awards to Drexel Univer...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced the selection of Distinguished Professors Michel Barsoum and Yury Gogotsi at and Professor Ananda Amarasekara at as recipients of an Agilent Solutions Innovation Research Award (SIRA). The three honorees will receive separate awards for their research into materials to advance energy storage technology. Environmental issues related to decades of fossil fuel use have sharply highlighted the need for more efficient and durable batteries. Creating global energy resources that are both renewable and sustainable presents a signif...
Agilent Reports First-Quarter Fiscal Year 2024 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.66 billion for the first quarter ended Jan. 31, 2024, a decline of 5.6% reported and 6.4% core(1) compared to the first quarter of 2023. First-quarter GAAP net income was $348 million, or $1.18 per share. This compares with $352 million, or $1.19 per share, in the first quarter of fiscal year 2023. Non-GAAP(2) net income was $380 million, or $1.29 per share during the quarter, compared with $406 million or $1.37 per share during the first quarter a year ago. “The Agilent team continued i...
Moody's announces completion of a periodic review of ratings of Agilen...
Moody's Investors Service (Moody's) has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 21 February 2024 in which Moody's reassessed the appropriateness of th...
Agilent Announces Cash Dividend of 23.6 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on April 24, 2024, to all shareholders of record as of the close of business on April 2, 2024. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to ...
Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that Padraig McDonnell, president of the Agilent CrossLab Group (ACG), has been named CEO-elect and chief operating officer (COO) of the company, succeeding current President and CEO Mike McMullen who will retire. McDonnell will become Agilent’s president and CEO and join Agilent’s Board of Directors on May 1. After nearly 40 years with Agilent and its predecessor Hewlett-Packard Co., McMullen will continue as CEO and as a member of the Agilent Board of Directors until May 1. He will then become an adv...
Agilent Ranked Among Top 50 Most Just Companies in America
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the company was again named one of the Most JUST Companies in America by Just Capital and CNBC. This marks the sixth year Agilent has appeared on the exclusive list, and the fourth year the company has ranked in the top 50. This press release features multimedia. View the full release here: The list highlights 100 companies that are performing best on business issues that matter most to the U.S. public, from paying a living wage and creating jobs to prioritizing accountability to all stakeholders. “I...
Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Deve...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year. These accolades highlight Agilent’s commitment to innovation and excellence in drug discovery and development. The Agilent was voted Best New Drug Discovery & Development Product of 2023. The Agilent xCELLigence RTCA HT-BioTek BioSpa 8 integrates the xCELLigence Real-Time Cell Analyzer (RTCA) HT instrument with the BioTek BioSpa 8 automated incubator to exp...
Agilent to Participate in TD Cowen Health Care Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston, Massachusetts, on Monday, March 4, at 2:50 p.m. EST. A live audio webcast and replay of the presentation will be available on the . About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of soluti...
Agilent Announces Collaboration with Incyte to Develop Advanced Compan...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced an agreement with that will bring together Agilent’s expertise and proven track record in the development of companion diagnostics (CDx) to support the development and commercialization of Incyte’s hematology and oncology portfolio. The value of the companion diagnostics market is predicted to expand to nearly US $14B by 2030,1 driven in part by the power of these tests to inform treatment decisions for a growing range of cancers and other chronic diseases. Developed for use with targeted therapeutics, companion diagnostics a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.